Related Experiment Video
Updated: Aug 7, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Atherosclerosis is an inflammatory disorder after all
1AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, Georgia 30004, USA. cmeng@atherogenics.com
Insights
Atherosclerosis is an inflammatory disease, not just high cholesterol. Statins reduce vascular inflammation and prevent heart disease by lowering cholesterol and through other anti-inflammatory mechanisms.
Area of Science:
- Cardiovascular Science
- Immunology
- Pharmacology
Background:
- Atherosclerosis was traditionally viewed as a cholesterol disorder.
- Emerging evidence highlights inflammation as a key driver in atherosclerosis pathogenesis.
- Cholesterol contributes to atherosclerosis via inflammatory pathways.
Purpose of the Study:
- To elucidate the role of inflammation in atherosclerosis.
- To discuss the anti-inflammatory effects of statins in cardiovascular disease.
- To explore novel therapeutic targets for atherosclerosis.
Main Methods:
- Review of current scientific literature on atherosclerosis and inflammation.
- Analysis of the mechanisms by which cholesterol impacts vascular inflammation.
- Evaluation of statin's cholesterol-dependent and independent anti-inflammatory actions.
Main Results:
- Atherosclerosis is fundamentally an inflammatory condition.
- Statins effectively reduce vascular inflammation, thereby preventing heart disease.
- Statins possess anti-inflammatory properties beyond cholesterol reduction.
Conclusions:
- Inflammation is central to atherosclerosis pathophysiology.
- Targeting inflammatory mechanisms offers a promising therapeutic strategy for atherosclerosis.
- Statins represent a crucial therapeutic intervention for managing atherosclerosis through combined lipid-lowering and anti-inflammatory effects.
Abstract:
Inflammation has been increasingly recognized as an important player in the pathophysiology of numerous human disorders. Accumulating evidence has led to the conclusion that atherosclerosis is an inflammatory disease, although it was believed to be a disorder of high cholesterol levels in the bloodstream for over a century. Cholesterol does contribute to the pathogenesis of atherosclerosis, but through inflammatory mechanisms. Statins lower cholesterol levels and hence reduce inflammation in the vasculature and prevent heart disease. Statins may also exert anti-inflammatory effects through mechanisms independent of cholesterol lowering. Adhesion molecules, cytokines, oxidative stress, etc. appear to contribute to the inflammatory state of atherosclerosis and therapeutic approaches directed toward these markers or targets have the potential to be effective in reducing inflammation and treating atherosclerosis.
Related Concept Videos
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease I: Introduction

